Connect with us

Hi, what are you looking for?

Stock

Oracle, Dell Dip in Thursday’s Market Cap Stock Movers

Thursday’s trading session is witnessing notable fluctuations among stocks across the board, with significant movements in both the mega-cap and large-cap categories. Oracle Corp (NYSE:ORCL) and Dell Inc (NYSE:DELL) are among the stocks experiencing declines, while MicroStrategy Inc (NASDAQ:MSTR) is surging. Here’s a look at some of the key stock movers today, spanning from mega-caps to small caps.

Mega-Cap Movers (Market Cap $200B+):

  • Oracle Corp (ORCL): -4.03%
  • Salesforce Com (NYSE:CRM): -3.84%
  • Avago Technologies (NASDAQ:AVGO): -3.08%
  • Servicenow Inc (NYSE:NOW): -2.68%
  • Adobe Sys Inc (NASDAQ:ADBE): -2.21%

Large-Cap Stock Movers (Market Cap $10B-$200B):

  • Dell Inc (DELL): -12.25%
  • Hewlett-pack (NYSE:HPQ): HP stock downgraded to Hold by HSBC on weak 1QFY25 outlook and rising commodity costs; -11.36%
  • MicroStrategy Inc (MSTR): +9.94%
  • Autodesk Inc (NASDAQ:ADSK): -8.59%
  • Nutanix Inc (NASDAQ:NTNX): Nutanix to Present at Upcoming Investor Conference; -7.81%
  • BeiGene (NASDAQ:BGNE): +7.31%
  • Reinvent Technology Partners Y (AUR): +7.27%
  • Li Auto Inc (NASDAQ:LI): American Lithium Reports Results of Annual General and Special Meeting; +6.78%
  • IBIT NASDAQ (IBIT): +6.44%
  • FBTC NYSE (FBTC): +6.37%

Mid-Cap Stock Movers (Market Cap $2B-$10B):

  • SVF Investment 3 (SYM): -35.87%
  • Iris Energy (IREN): +29.71%
  • Arrowhead Research Corp (NASDAQ:ARWR): +24.23%
  • Urban outfitters (NASDAQ:URBN): +18.31%
  • Hut 8 Mining PK (HUT): +16.5%
  • HCM Acquisition (MRNO): +16.17%
  • Good Works Acquisition (CIFR): +14.56%
  • MSTU (MSTU): +13.93%

Small-Cap Stock Movers (Market Cap $300M-$2B):

  • Advanced Photonix Inc (API): +33.97%
  • ETHU (ETHU): +18.79%
  • Golden Bull (BTBT): +18.45%
  • Fate Therap (NASDAQ:FATE): +18.28%
  • Kingsoft Cloud Holdings Ltd (KC): +17.42%
  • Immunome Inc (NASDAQ:IMNM): +16.83%
  • Wowo Ltd (MFH): -16.32%
  • Semler Scientifc (NASDAQ:SMLR): +16.06%
  • Applied Therapeutics Inc (NASDAQ:APLT): FDA declines approval for Applied Therapeutics’ Galactosemia drug; -16.06%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You May Also Like

Investing

In the days since President-elect Donald Trump won the presidential race, Nicole Bivens Collinson’s phone has barely stopped ringing. Collinson, who helps lead the...

Investing

Netflix’s cheaper, ad-supported tier has reached 70 million global monthly active users two years after it was launched. The company said Tuesday more than...

Editor's Pick

Adani Group shares experienced a rebound on Monday, recovering from last week’s steep losses sparked by U.S. criminal charges against Chairman Gautam Adani and...

Stock

Investing.com – Trip.com ADR (NASDAQ: TCOM) reported third quarter EPS of ¥7.05, ¥0.12 better than the analyst estimate of ¥6.93. Revenue for the quarter...



Disclaimer: Techreportdiversity.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2024 Techreportdiversity.com